1. Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep.
- Author
-
Piacenza L, Acosta D, Basmadjian I, Dalton JP, and Carmona C
- Subjects
- Animals, Antibodies, Helminth immunology, Antigens, Helminth isolation & purification, Cathepsin L, Cathepsins isolation & purification, Cysteine Endopeptidases isolation & purification, Enzyme-Linked Immunosorbent Assay, Fascioliasis prevention & control, Immunoblotting, Liver enzymology, Sheep, Sheep Diseases parasitology, Snails, Antigens, Helminth immunology, Cathepsins immunology, Cysteine Endopeptidases immunology, Endopeptidases, Fascioliasis veterinary, Leucyl Aminopeptidase immunology, Sheep Diseases prevention & control, Vaccination
- Abstract
The potential of different parasite proteinases for use as vaccine candidates against fascioliasis in sheep was studied by vaccinating animals with the cathepsin L proteinases CL1 and CL2 and with leucine aminopeptidase (LAP) purified from adult flukes. In the first trial, sheep were immunized with CL1 or CL2 and the mean protection levels obtained were 33 and 34%, respectively. Furthermore, a significant reduction in egg output was observed in sheep vaccinated either with CL1 (71%) or with CL2 (81%). The second trial was performed to determine the protective potential of the two cathepsin L proteinases assayed together, as well as in combination with LAP, and of LAP alone. The combination of CL1 and CL2 induced higher levels of protection (60%) than those produced when these enzymes were administered separately. Those sheep that received the cocktail vaccine including CL1, CL2, and LAP were significantly protected (78%) against metacercarial challenge, but vaccination with LAP alone elicited the highest level of protection (89%). All vaccine preparations induced high immunoglobulin G titers which were boosted after the challenge infection, but no correlations between antibody titers and worm burdens were found. However, the sera of those animals vaccinated with LAP contained LAP-neutralizing antibodies. Reduced liver damage, as assessed by the level of the liver enzyme gamma-glutamyl transferase, was observed in the groups vaccinated with CL1, CL2, and LAP or with LAP alone.
- Published
- 1999
- Full Text
- View/download PDF